|
Presented as a poster at the 18th Annual Sympposium of the International Society for Technology in Athroplasty (September 29 - October 2, 2005, Kyoto, Japan)
DETAIL - A group of 22 complex and severe chronic patients received three 30 minute treatments with the InterX 5000 delivered over three days. All 22 had significant complain of pain inspite of management by invasive procedures and pain medication. After treatment, the average reduction in pain scores was from 6 out of 10 to less than 2 out of 10.
The results represent a 79% decrease in average pain scores and statistical analysis showed a p-values of < .001. A statistically significant reduction in pain of this degree indicates a high probability (99.9%) of these results being replicated in similar groups.
It was also noted that 40% of patients voluntarily reduced their intake of pain medication (duragesic patch, hydrocodone, etc.)
Direct costs as submitted to NRG via a budget document for staffing, testing, treatment and subject compensation are acceptable expenses and will be paid as well as other mutually agreed upon expenses. As a start-up company it is our policy to pay indirect costs up to a maximum rate of 30% or less.
|
